Ortega-Gutiérrez S - Search Results

1

Development of a Nucleotide Exchange Inhibitor That Impairs Ras Oncogenic Signaling.

Marín-Ramos NI, Piñar C, Vázquez-Villa H, Martín-Fontecha M, González Á, Canales Á, Algar S, Mayo PP, Jiménez-Barbero J, Gajate C, Mollinedo F, Pardo L, Ortega-Gutiérrez S, Viso A, López-Rodríguez ML. Marín-Ramos NI, et al. Chemistry. 2017 Jan 31;23(7):1676-1685. doi: 10.1002/chem.201604905. Epub 2016 Dec 27. Chemistry. 2017. PMID: 27885731 Free article.

2

Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Lastres-Becker I, González S, Fernández-Ruiz J, Ramos JA. López-Rodríguez ML, et al. J Med Chem. 2001 Dec 20;44(26):4505-8. doi: 10.1021/jm015545y. J Med Chem. 2001. PMID: 11741470

3

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide.

de Lago E, Fernández-Ruiz J, Ortega-Gutiérrez S, Viso A, López-Rodríguez ML, Ramos JA. de Lago E, et al. Eur J Pharmacol. 2002 Aug 2;449(1-2):99-103. doi: 10.1016/s0014-2999(02)01996-9. Eur J Pharmacol. 2002. PMID: 12163112

4

Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, de Lago E, Fernández-Ruiz J, Ramos JA. López-Rodríguez ML, et al. J Med Chem. 2003 Apr 10;46(8):1512-22. doi: 10.1021/jm0210818. J Med Chem. 2003. PMID: 12672252

5

Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, de Lago E, Fernández-Ruiz J, Ramos JA. López-Rodríguez ML, et al. Eur J Med Chem. 2003 Apr;38(4):403-12. doi: 10.1016/s0223-5234(03)00045-x. Eur J Med Chem. 2003. PMID: 12750028

6

Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin.

Fowler CJ, Tiger G, López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Ramos JA. Fowler CJ, et al. J Enzyme Inhib Med Chem. 2003 Jun;18(3):225-31. doi: 10.1080/1475636031000080216. J Enzyme Inhib Med Chem. 2003. PMID: 14506913

7

VR1 receptor modulators as potential drugs for neuropathic pain.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S. López-Rodríguez ML, et al. Mini Rev Med Chem. 2003 Nov;3(7):729-48. doi: 10.2174/1389557033487845. Mini Rev Med Chem. 2003. PMID: 14529514 Review.

8

Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.

Ruiz-Llorente L, Ortega-Gutiérrez S, Viso A, Sánchez MG, Sánchez AM, Fernández C, Ramos JA, Hillard C, Lasunción MA, López-Rodríguez ML, Díaz-Laviada I. Ruiz-Llorente L, et al. Br J Pharmacol. 2004 Feb;141(3):457-67. doi: 10.1038/sj.bjp.0705628. Epub 2004 Jan 12. Br J Pharmacol. 2004. PMID: 14718261 Free PMC article.

9

Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.

Ortega-Gutiérrez S, Hawkins EG, Viso A, López-Rodríguez ML, Cravatt BF. Ortega-Gutiérrez S, et al. Biochemistry. 2004 Jun 29;43(25):8184-90. doi: 10.1021/bi049395f. Biochemistry. 2004. PMID: 15209515

10

Involvement of cannabinoids in cellular proliferation.

López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Díaz-Laviada I. López-Rodríguez ML, et al. Mini Rev Med Chem. 2005 Jan;5(1):97-106. doi: 10.2174/1389557053402819. Mini Rev Med Chem. 2005. PMID: 15638794 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page